Effects of experimental recombinant interferons on multiple sclerosis.
作者信息
Johnson K P, Panitch H S
机构信息
Department of Neurology, University of Maryland School of Medicine, Baltimore.
出版信息
Trans Am Clin Climatol Assoc. 1989;100:171-6.
Abstract
摘要
相似文献
1
Effects of experimental recombinant interferons on multiple sclerosis.实验性重组干扰素对多发性硬化症的影响。
Trans Am Clin Climatol Assoc. 1989;100:171-6.
2
Treatment of multiple sclerosis with various interferons: the cons.使用多种干扰素治疗多发性硬化症：反对观点
Neurology. 1988 Jul;38(7 Suppl 2):62-5.
3
The interferons: biological effects, mechanisms of action, and use in multiple sclerosis.
Ann Neurol. 1995 Jan;37(1):7-15. doi: 10.1002/ana.410370105.
4
New hope for multiple sclerosis victims via an improved, inexpensive, orthomolecular, interferon clinical protocol.通过改进的、廉价的、正分子的干扰素临床方案为多发性硬化症患者带来新希望。
Australas Nurses J. 1982 Apr;11(3):13-5.
5
Interferon therapy for multiple sclerosis.用于治疗多发性硬化症的干扰素疗法。
Md Med J. 1992 Jul;41(7):601-3.
6
Immunological basis for the therapy of multiple sclerosis.多发性硬化症治疗的免疫学基础。
Acta Neurol Belg. 1999 Mar;99(1):40-3.
7
Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis.
J Infect Dis. 1982 Jul;146(1):109-15. doi: 10.1093/infdis/146.1.109.
8
[Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results].[干扰素治疗多发性硬化症。作用机制、副作用、疗效]
Nervenarzt. 1988 Sep;59(9):514-20.
9
Biologic effects of interferons: relevance to multiple sclerosis.干扰素的生物学效应：与多发性硬化症的相关性。
Mult Scler. 1995;1 Suppl 1:S12-6.
10
[Etiology and treatment of multiple sclerosis].[多发性硬化症的病因及治疗]
Nihon Naika Gakkai Zasshi. 2001 Sep 10;90(9):1827-32.
本文引用的文献
1
Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic.
Neurology. 1982 Feb;32(2):143-50. doi: 10.1212/wnl.32.2.143.
2
Systemic alpha-interferon therapy of multiple sclerosis.多发性硬化症的全身α-干扰素治疗
Neurology. 1984 Oct;34(10):1273-9. doi: 10.1212/wnl.34.10.1273.
3
Systemic interferon therapy for multiple sclerosis. Design of a trial.用于多发性硬化症的全身干扰素治疗。一项试验的设计。
Arch Neurol. 1983 Oct 21;40(11):681-2. doi: 10.1001/archneur.1983.04050100021007.
4
Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis.系统性重组α-2干扰素治疗复发型多发性硬化症。
Arch Neurol. 1986 Dec;43(12):1239-46. doi: 10.1001/archneur.1986.00520120023011.
5
Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system.用γ干扰素治疗多发性硬化症：与免疫系统激活相关的病情加重。
Neurology. 1987 Jul;37(7):1097-102. doi: 10.1212/wnl.37.7.1097.
6
Clinical viral infections and multiple sclerosis.临床病毒感染与多发性硬化症
Lancet. 1985 Jun 8;1(8441):1313-5. doi: 10.1016/s0140-6736(85)92801-6.
7
Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis.多发性硬化症中不存在病毒诱导的淋巴细胞抑制和干扰素产生。
Proc Natl Acad Sci U S A. 1979 Jan;76(1):476-80. doi: 10.1073/pnas.76.1.476.
8
Multiple sclerosis: diagnostic usefulness of cerebrospinal fluid.多发性硬化症：脑脊液的诊断价值
Ann Neurol. 1977 Nov;2(5):425-31. doi: 10.1002/ana.410020515.
Zotero 插件